Ryan Spencer insider trades

Open-market stock purchases and sales by Ryan Spencer, CEO and Director at Dynavax Technologies Corp, from SEC Form 4 filings since Jun 2, 2019.

Recent trades

DateStockTradeValue
Feb 10, 2026DVAX Dynavax Technologies CorpSold (not open market)—
Feb 10, 2026DVAX Dynavax Technologies CorpBought (not open market)—
Feb 10, 2026DVAX Dynavax Technologies CorpSold (not open market)—
Feb 10, 2026DVAX Dynavax Technologies CorpSold (not open market)$191K
Feb 10, 2026DVAX Dynavax Technologies CorpSold (not open market)$2.7M
Feb 10, 2026DVAX Dynavax Technologies CorpSold (not open market)—
Feb 10, 2026DVAX Dynavax Technologies CorpSold (not open market)—
Feb 10, 2026DVAX Dynavax Technologies CorpSold (not open market)$679K
Feb 10, 2026DVAX Dynavax Technologies CorpSold (not open market)$2.4M
Feb 10, 2026DVAX Dynavax Technologies CorpSold (not open market)$4.5M
Feb 10, 2026DVAX Dynavax Technologies CorpSold (not open market)$3.1M
Feb 10, 2026DVAX Dynavax Technologies CorpSold (not open market)$2.9M
Feb 10, 2026DVAX Dynavax Technologies CorpSold (not open market)$2.9M
Feb 10, 2026DVAX Dynavax Technologies CorpSold (not open market)—
Feb 10, 2026DVAX Dynavax Technologies CorpBought (not open market)—
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$53.7K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$26.9K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$237K
Dec 24, 2025DVAX Dynavax Technologies CorpSold (not open market)$2.1M
Dec 23, 2025DVAX Dynavax Technologies CorpBought (not open market)—
Dec 23, 2025DVAX Dynavax Technologies CorpBought (not open market)—
Dec 23, 2025DVAX Dynavax Technologies CorpBought (not open market)—

Companies traded

  • DVAX Dynavax Technologies Corp: 4 sales, last Feb 10, 2026
  • CDTX Cidara Therapeutics, Inc: other filings, last Jan 7, 2026

Get free alerts when Ryan Spencer files a new trade →